| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |